1-1(Z)-Hexadecenyl-2-Arachidonoyl-sn-glycero-3-PC (Synonyms: 1-1(Z)-Hexadecenyl-2-Arachidonoyl-sn-glycero-3-Phosphocholine, 1-1(Z)-Hexadecenyl-2-Arachidonoyl-sn-glycero-3-Phosphatidylcholine, 16:0p/20:4-PC, PC(P-16:0/20:4), C16(plasm)-20:4-PC, PlgPC 16:0/20:4) |
| Catalog No.GC52356 |
A plasmalogen
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 84460-45-7
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
1-1(Z)-Hexadecenyl-2-arachidonoyl-sn-glycero-3-PC is a plasmalogen that contains 1(Z)-hexadecenoic acid and arachidonic acid at the sn-1 and sn-2 positions, respectively. Serum levels of 1-1(Z)-hexadecenyl-2-arachidonoyl-sn-glycero-3-PC are decreased in dogs with myxomatous mitral valve disease when fed a diet including medium chain triglycerides, fish oil, carnitine precursors, magnesium, and antioxidants.1
1.Li, Q., Laflamme, D.P., and Bauer, J.E.Serum untargeted metabolomic changes in response to diet intervention in dogs with preclinical myxomatous mitral valve diseasePLoS One15(6)e0234404(2020)
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *